Cubist Systematic Strategies, LLC Landec Corp \Ca\ Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	N/A	10,538 New	10,538 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $9.95 $0 - $52,506	5,277 Added 1570.54%	5,613 $0
Q3 2022 Nov 14, 2022	BUY	$8.57 - $11.57 $2,656 - $3,586	310 Added 1192.31%	336 $3,000
Q2 2022 Aug 15, 2022	SELL	$8.84 - $11.64 $82,185 - $108,217	-9,297 Reduced 99.72%	26 $0
Q1 2022 May 16, 2022	BUY	$10.07 - $11.93 $93,882 - $111,223	9,323 New	9,323 $108,000
Q3 2021 Nov 15, 2021	SELL	$9.22 - $12.44 $106,767 - $144,055	-11,580 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.91 - $12.78 $114,757 - $147,992	11,580 New	11,580 $130,000

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.